Moreover, PD-L1 and -L2 are present on tumor-infiltrating DCs, especially CD1a+ subsets, potentially suppressing anti-tumor immune responses and aiding immune evasion in cSCC [93]. This evidence concerns the gene CD274 and neoplasm.